Exosome Diagnostics Positioned for Growth as G2 Tech Group Streamlines Their Transition to Amazon Web Services

Shortly after G2 architected our AWS environment, we closed on three new partners and now have several more in our pipeline — G2 plays a key role in our company’s growth.
John Healy
Vice President of Informatics

The Challenge

The Healthcare Industry quickly recognized the value of Exosome Diagnostics’ ability to avoid biopsies by using biofluid diagnostics to detect molecular mutations in tumors based on RNA, DNA and proteins extracted from exosomes. As several large pharmaceutical companies indicated a desire to form a strategic partnership with Exosome, they realized the time had arrived to increase the company’s technology capacity.

Explains Healy, “We were relying on a hosted private cloud IT environment that could not scale to handle the interactions we anticipated having with pharmaceutical firms through our Laboratory Information Management System, the primary application that drives our business and which requires heavy processing. We thus wanted to move our existing infrastructure to the Amazon Web Services (AWS) public cloud platform.”

The Solution

Exosome looked at partners who could deploy and manage AWS environments. But none of them received serious consideration after the initial meetings with G2 Tech Group.

“The many real-world AWS solutions G2 has built in the past are very impressive, and then meeting the team in person convinced us of their technical prowess and responsiveness,” say Healy. “It has been a cooperative engagement from the outset—G2 does not try to dictate what we should do, yet they offer solid knowledge of the best practices to consider.”

Tech Services Used

  • Relational Database Service (RDS)
  • Elastic Compute Cloud (EC2)
  • Virtual Private Cloud (VPC)
  • Virtual Private Networks (VPN)
  • Simple Storage Service (S3)
  • Multi-Region Availability Zones
  • Elastic Block Store (EBS)
  • CloudTrail
  • Identify and Access Management (IAM)

The Results

  • Streamlines the launch of a new business model to enable online collaboration with pharmaceutical companies.
  • Provides controlled online content sharing (via where sensitive documents can be protected from access by unauthorized end users.
  • Ensures IT infrastructure operates reliably and optimally for end users in the US and in Germany.
  • Creates a scalable infrastructure that can expand quickly as business requirements change.
  • Generates alerts and provides support before compute resources experience performance issues so potential problems can be mitigated before end users are impacted.
  • Reduces cloud-computing costs by ensuring efficient usage of virtual server reserved instances—automatically turning them off when no longer needed.

The cutover for end users went smoothly as G2 set up the Laboratory Information Management System, AWS Amazon Simple Storage Service (Amazon S3), a QuickBooks server and Microsoft Office 365. G2 also configured OKTA, a cloud-based identity and access management solution that gives users quick access to all AWS systems.

“The AWS monitoring provided by G2’s DevOps Accelerator helps us know if a hard disc, for example, is filling up ahead of time, and then they make the necessary changes in advance so our work day does not get interrupted,” says Vasisht Tadigotla, Head of Informatics at Exosome Diagnostics. “This allows us to focus our time on strategic projects rather than provisioning and monitoring IT. G2 is a great partner to help us take the company forward.”

Talk to Us

Speak with G2 Tech Group now, call 888-699-8696 x1.

G2 Tech Group is ready to handle your cloud needs. Get in touch with the AWS Startup Experts and see how we can help.